How Daily Function Measures Shape Dementia Drug Approvals

Daily function measures like CDR-SB and ADAS-Cog are the regulatory currency that determines which dementia drugs get FDA approval.

Daily function measures like CDR-SB and ADAS-Cog are the regulatory currency that determines which dementia drugs get FDA approval.

Exercise is one of the most powerful tools available for reducing your risk of dementia, functioning as a protective mechanism that strengthens brain...

Walking programs offer older adults at risk a powerful, low-cost tool for preventing serious health conditions and maintaining independence.

Physical activity appears so consistently in dementia research because it directly affects the brain's structure and function through multiple biological...

Yes, exercise can significantly influence Alzheimer's risk—research consistently shows that people who maintain regular physical activity have a lower...

A genuine dementia breakthrough differs from marketing hype by meeting three core standards: it must be published in peer-reviewed journals, show results...

Alzheimer's blood tests represent a major breakthrough in detecting early signs of cognitive decline, but they have a critical limitation that often gets...

The gap between promising Alzheimer's research and proven therapy is measured in years of clinical evidence, billions of dollars, and the regulatory...

Fundraising walks remain important in Alzheimer's advocacy because they serve as the primary mechanism connecting community participation directly to...

Yes, Alzheimer's walks can genuinely help families feel less alone—but only if they address the specific kind of isolation that caregivers experience.